HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 297 filers reported holding HAEMONETICS CORP in Q3 2023. The put-call ratio across all filers is 0.12 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,470,635 | +22.5% | 16,417 | +16.4% | 0.13% | +27.7% |
| Q2 2023 | $1,200,985 | +4.5% | 14,106 | +1.6% | 0.10% | +2.0% |
| Q1 2023 | $1,149,398 | +18.4% | 13,890 | +12.5% | 0.10% | +28.6% |
| Q4 2022 | $970,777 | +26.2% | 12,343 | +18.8% | 0.08% | -4.9% |
| Q3 2022 | $769,000 | +13.8% | 10,389 | +0.1% | 0.08% | +19.1% |
| Q2 2022 | $676,000 | +30.3% | 10,376 | +26.4% | 0.07% | +44.7% |
| Q1 2022 | $519,000 | +68.0% | 8,211 | +40.7% | 0.05% | +74.1% |
| Q4 2021 | $309,000 | -8.8% | 5,834 | +21.5% | 0.03% | -22.9% |
| Q3 2021 | $339,000 | +24.2% | 4,803 | +17.2% | 0.04% | +29.6% |
| Q2 2021 | $273,000 | +1.9% | 4,098 | +69.5% | 0.03% | -10.0% |
| Q1 2021 | $268,000 | -6.9% | 2,417 | -0.5% | 0.03% | -16.7% |
| Q4 2020 | $288,000 | +42.6% | 2,428 | +4.8% | 0.04% | +24.1% |
| Q3 2020 | $202,000 | +119.6% | 2,317 | +126.5% | 0.03% | +123.1% |
| Q2 2020 | $92,000 | 0.0% | 1,023 | +11.3% | 0.01% | -18.8% |
| Q1 2020 | $92,000 | – | 919 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Nitorum Capital, L.P. | 413,122 | $16,608,000 | 4.78% |
| Altalis Capital Management LLC | 88,055 | $3,540,000 | 3.97% |
| RUTABAGA CAPITAL MANAGEMENT LLC/MA | 513,619 | $20,647,000 | 3.54% |
| Black Creek Investment Management Inc. | 1,118,613 | $44,968,000 | 3.46% |
| HealthCor Management, L.P. | 1,150,000 | $46,230,000 | 2.61% |
| Van Berkom & Associates Inc. | 1,136,971 | $45,706,000 | 1.83% |
| AMERICAN CAPITAL MANAGEMENT INC | 567,896 | $22,829,000 | 1.77% |
| FULLER & THALER ASSET MANAGEMENT, INC. | 2,062,539 | $82,914,000 | 1.25% |
| Legato Capital Management LLC | 1,336 | $53,707,000 | 0.97% |
| HEARTLAND ADVISORS INC | 351,314 | $14,123,000 | 0.78% |